Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | huntingtin | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | neuropeptide S receptor 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2265 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0558 | 0.6994 | 1 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0039 | 0.0053 | 0.0156 |
Trichomonas vaginalis | esterase, putative | 0.0039 | 0.0053 | 1 |
Mycobacterium ulcerans | beta-lactamase | 0.0039 | 0.0053 | 0.5 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0287 | 0.3368 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0053 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0039 | 0.0053 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.011 | 0.1004 | 0.2982 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.0538 | 0.1598 |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0.0053 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.011 | 0.1004 | 0.2982 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0249 | 0.2865 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0039 | 0.0053 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0048 | 0.0178 | 0.0786 |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.2705 | 0.8031 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1508 | 0.4477 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0111 | 0.0159 |
Mycobacterium ulcerans | lipase LipD | 0.0039 | 0.0053 | 0.5 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.0053 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.2265 | 0.2265 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.0053 | 0.0156 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0053 | 1 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0039 | 0.0053 | 0.0075 |
Schistosoma mansoni | hypothetical protein | 0.0048 | 0.0178 | 0.0786 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0039 | 0.0053 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0287 | 0.3368 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0111 | 0.0491 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.1508 | 0.4477 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0111 | 1 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.0053 | 0.0156 |
Echinococcus granulosus | geminin | 0.0205 | 0.2265 | 0.3239 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0075 | 0.0538 | 0.1598 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.011 | 0.1004 | 0.2982 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0111 | 1 |
Mycobacterium leprae | conserved hypothetical protein | 0.0039 | 0.0053 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.0053 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0558 | 0.6994 | 0.6994 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0237 | 0.2705 | 0.2705 |
Loa Loa (eye worm) | hypothetical protein | 0.011 | 0.1004 | 0.2982 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0039 | 0.0053 | 0.0156 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.2265 | 1 |
Brugia malayi | hypothetical protein | 0.0148 | 0.1508 | 0.4477 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0237 | 0.2705 | 0.3867 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0039 | 0.0053 | 1 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0558 | 0.6994 | 0.6994 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0111 | 0.0331 |
Plasmodium falciparum | basic transcription factor 3b, putative | 0.0035 | 0 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.0053 | 0.0232 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0053 | 0.0156 |
Mycobacterium leprae | Probable lipase LipE | 0.0039 | 0.0053 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0075 | 0.0538 | 0.2375 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0039 | 0.0053 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.0053 | 0.0232 |
Toxoplasma gondii | ABC1 family protein | 0.0039 | 0.0053 | 1 |
Loa Loa (eye worm) | beta-lactamase | 0.0039 | 0.0053 | 0.0156 |
Brugia malayi | hypothetical protein | 0.0237 | 0.2705 | 0.8031 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0048 | 0.0178 | 0.0529 |
Brugia malayi | beta-lactamase | 0.0039 | 0.0053 | 0.0156 |
Plasmodium vivax | hypothetical protein, conserved | 0.0039 | 0.0053 | 1 |
Onchocerca volvulus | 0.0048 | 0.0178 | 0.0862 | |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0111 | 0.0491 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.1508 | 1 |
Echinococcus granulosus | neuropeptide s receptor | 0.0558 | 0.6994 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0148 | 0.1508 | 1 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0039 | 0.0053 | 0.0053 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0039 | 0.0053 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0111 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0111 | 0.0111 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0039 | 0.0053 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0111 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.6535 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 18.3564 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 79.4328 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.